Pharmacy Practice Review
Type 2 diabetes: a patient-centred approach
Update your knowledge about the range of glucose-lowering medicines available and their role in the treatment of type 2 diabetes.
It is recommended that up to 8 hours of Group 3 CPD (or 24 CPD credits) be recorded for the purposes of self-directed pharmacist CPD.
Express version requires only 5 episodes of care
1. Express version: 5 episodes of care for 5 hours of Group 3 CPD (or 15 CPD credits)
2. Standard version: 10 episodes of care for 8 hours of Group 3 CPD (or 24 CPD credits)
You will be given the option to submit your data once 5 episodes of care are entered, or continue to 10 episodes of care.
Read the FAQs
An opportunity to reflect on your current management of patients with type 2 diabetes. Update your knowledge about the range of glucose-lowering medicines available and their role in the treatment of type 2 diabetes. How can you improve the way you support your patients with type 2 diabetes to achieve good glycaemic control and optimise long-term health outcomes?
On completion of this activity you should be able to:
- assess and recommend strategies to promote adherence to metformin and glucose-lowering medicines in people with type 2 diabetes
- outline the role of add-on medicines to metformin in the context of the latest treatment recommendations for type 2 diabetes
- support patients in the self-management of type 2 diabetes, including education about lifestyle modifications and ongoing monitoring
- outline potential adverse effects of glucose-lowering medicines and recommend management options for adverse effects.
You will have access to:
- up-to-date clinical guidance which provides evidence-based information to update your knowledge and guide your counselling encounters with patients
- pharmacist tools that inform and support your best practice discussions with patients
- expert commentary from pharmacist and clinical educator, Jane Ludington (St Vincent’s Hospital, University of Sydney).